THURSDAY, April 23 (HealthDay News) -- Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) and interstitial cystitis/painful bladder syndrome (IC/PBS) have a similar and significant economic impact, according to a study published in the April issue of Urology.
J. Quentin Clemens, M.D., of the University of Michigan in Ann Arbor, and colleagues studied 62 men with CP/CPPS and 43 women with IC/PBS.
The researchers found that the annualized direct costs per person were $3,631 for IC/PBS and $3,017 for CP/CPPS under Medicare rates, and $7,043 for IC/PBS and $6,534 for CP/CPPS under non-Medicare rates. They also found that 16 (26 percent) of CP/CPPS and eight (19 percent) of IC/PBS patients reported wage loss because of their condition.
"Regardless of the cost mechanism used (Medicare or non-Medicare), the direct costs of these conditions are greater than the mean yearly costs reported for many other chronic pain conditions," the authors conclude. "The substantial costs associated with CP/CPPS and IC/PBS support ongoing efforts to educate physicians about these conditions and to identify effective treatments."
Abstract
Full Text (subscription or payment may be required)
